Loading…
Please register to continue your trial period!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Ths randomized, double‑blind, placebo‑controlled prevention trial revealed that Lacticaseibacillus casei LC2W can help prevent Metabolic Syndrome (MetS) by improving clinical outcomes and modulating microflora. This offers a potential alternative strategy for individuals who are at high risk of developing MetS.